Refractory adult onset Still's disease successfully treated with anakinra

Annals of the Rheumatic Diseases

Volumn 64, Issue 4, 2005, Pages 647-648

  Vasques Godinho, F M ^a   Parreira Santos, M J ^a   Canas Da Silva, J ^a  

^a HOSPITAL GARCIA DE ORTA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FERRITIN; HEMOGLOBIN; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; NAPROXEN; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE;

ADULT; ADULT ONSET STILL DISEASE; ANEMIA; ARTHRALGIA; ARTHRITIS; ARTICLE; ASEPTIC NECROSIS; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; THROMBOCYTE COUNT; TOTAL HIP PROSTHESIS;

ADULT; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; STILL'S DISEASE, ADULT-ONSET;

EID: 16344364963     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.026617     Document Type: Article

References (10)

1. Fujii T, Nojima T, Yasuoka S, Satoh S, Nakamura K, Kuwana M, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford) 2001;40:1398-404.
2. Vencovský J, Jarošová K, Ružič ková S, Nemcova D, Niederlova J, Ozen S, et al. Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis Rheum 2001;44:2387-91.
3. Müller K, Herner E, Stagg A, Bendtzen K, Woo P. Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. Br J Rheumatol 1998;37:562-9.
4. Elliott M, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-α (cA2). Br J Rheumatol 1997;36:589-93.
5. Wilkinson N, Jackson G, Gardner-Medwin J. Biologic therapies for juvenile arthritis. Arch Dis Child 2003;88:186-91.
6. Marchesoni A, Ceravolo GP, Battafarano N, Rossetti A, Tosi S, Fantini F. Cyclosporin A in the treatment of adult Still's disease. J Rheumatol 1997;24:1582-7.
7. Fujii T, Akizuki M, Kameda H, Matsumura M, Hirakata M, Yoshida T, et al. Methotrexate treatment in patients with adult Still's disease: retrospective study of 13 Japanese cases. Ann Rheum Dis 1997;56:144-8.
8. Husni M, Maier A, Mease P, Overman SS, Fraser P, Gravallese EM, et al. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 2002;46:1171-6.
9. Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 2004;23:45-9.
10. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.